Aytu BioPharma (AYTU) Insider Trading & Ownership $1.35 -0.03 (-2.17%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$1.37 +0.02 (+1.19%) As of 02/21/2025 06:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends Aytu BioPharma (NASDAQ:AYTU) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.77%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$97,201.62Number OfInsiders Selling(Last 3 Years)0 Get AYTU Insider Trade Alerts Want to know when executives and insiders are buying or selling Aytu BioPharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AYTU Insider Buying and Selling by Quarter Aytu BioPharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/16/2023Greg PyszczymukaInsiderBuy12,000$1.87$22,440.00 6/14/2023Joshua R DisbrowCEOBuy14,000$1.86$26,040.00 12/19/2022Greg PyszczymukaInsiderBuy100,000$0.24$24,000.00 12/19/2022Joshua R DisbrowCEOBuy112,371$0.22$24,721.62 (Data available from 1/1/2013 forward) AYTU Insider Trading Activity - Frequently Asked Questions Who is on Aytu BioPharma's Insider Roster? The list of insiders at Aytu BioPharma includes Greg Pyszczymuka, and Joshua R Disbrow. Learn more on insiders at AYTU. What percentage of Aytu BioPharma stock is owned by insiders? 2.77% of Aytu BioPharma stock is owned by insiders. Learn more on AYTU's insider holdings. Which Aytu BioPharma insiders have been buying company stock? The following insiders have purchased AYTU shares in the last 24 months: Greg Pyszczymuka ($22,440.00), and Joshua R Disbrow ($26,040.00). How much insider buying is happening at Aytu BioPharma? Insiders have purchased a total of 26,000 AYTU shares in the last 24 months for a total of $48,480.00 bought. Aytu BioPharma Key ExecutivesMr. Joshua R. Disbrow (Age 49)Chairman & CEO Compensation: $708kMr. Mark K. Oki CPA (Age 55)CFO, Secretary & Treasurer Compensation: $522.84kMs. Victoria CordovaVice President of People & CultureMr. Jarrett T. Disbrow Ph.D. (Age 49)Chief Business Officer & President of Consumer Health Compensation: $355kMr. Russ McMahenSenior Vice President of Research & DevelopmentMr. Ryan J. Selhorn CPA (Age 42)Executive VP of Finance & Business Optimization More Insider Trading Tools from MarketBeat Related Companies CVKD Insider Transactions CALC Insider Transactions IBIO Insider Transactions VRCA Insider Transactions EQ Insider Transactions QTTB Insider Transactions BIVI Insider Transactions PLUR Insider Transactions SNYR Insider Transactions BFRG Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:AYTU) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredA strange twist 500 miles from WashingtonEnergy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aytu BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aytu BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
